Melanoma/Skin Cancer News

The FDA approved atezolizumab and hyaluronidase-tqjs for subcutaneous injection.

Veterans experience higher prevalence rates of skin cancer, especially melanoma, and psoriasis compared with nonveterans, according to a study.

The DecisionDx-SCC test successfully identified which patients with cutaneous squamous cell carcinoma would most likely benefit from adjuvant radiation therapy, according to a study.

The FDA has not approved a new sunscreen ingredient since the 1990s, leaving consumers and clinicians wondering why.

The first patient has been enrolled in a phase 2 clinical trial of D-MNA for the treatment of basal cell carcinoma, Medicus Pharma announced in a press release.

Two randomized phase 3 trials of pembrolizumab — one in lung cancer and one in skin cancer — have been discontinued due to lack of efficacy, according to the agent’s manufacturer.

A novel therapeutic approach stimulated new and existing T-cell responses among patients with melanoma or non-small cell lung cancer, according to results of a phase 1 trial.

Patients with cancer who received immune checkpoint inhibitors rarely developed cardiovascular adverse events, according to results of a systematic review and meta-analysis.

Spouses of people with cancer exhibited significantly higher risk for attempted suicide and suicide death than those whose spouses had not been diagnosed with cancer, according to a nationwide cohort study in Denmark.

The lack of surgical instruments tailored for women’s hands is just one example of the gender inequity female surgeons face in the workforce.